Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

Inari Medical, Inc. (NARI)

Sector - Healthcare

Price chart

N/A
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Their initial product offering consists of two minimally-invasive, novel catheter-based mechanical thrombectomy devices. They purpose-built their products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE -- deep vein thrombosis and pulmonary embolism. Their ClotTriever product is FDA-cleared for the removal of clot from peripheral blood vessels and is used to treat patients suffering from deep vein thrombosis, or DVT. Their FlowTriever product is the first thrombectomy system FDA-cleared for the treatment of pulmonary embolism, or PE. These products have been used to treat more than 6,700 patients at approximately 500 hospitals across the United States, with approximately 90% of cases being performed since they launched their broader commercial efforts in the third quarter of 2018. They have experienced significant growth since they began commercializing their products and have had strong momentum in their business in 2019, with 4,562 procedures performed using their products in 2019.
Industry
Surgical & Medical Instruments & Apparatus
CEO CFO
William Hoffman Mitchell Hill
Employees Founded
240 2011

Contacts

Address: 9 Parker, Suite 100, Irvine, Ca 92618, Us

Telephone: (877) 923-4747

Web page: http://www.inarimedical.com

IPO information

First Trade Date 5/22/2020
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range $14.00-$16.00
Share prices ($)

Shares & Volumes

Shares Initial (MM) 7.33
Shares Revised (MM) 8.2
Expected offer amount (MM) $109.95
Realized offer amount(MM) $155.8

Financial Data (last reporting year)

Market Cap (MM) $806.4
Revenues (MM) $71.1
Net Income (Loss) (MM) $3.9

Voting

What do you think will happen with the NARI share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: BofA Securities

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
BofA Securities/ Morgan Stanley
CO-Managers
Canaccord Genuity/ Wells Fargo Securities

Sector: Healthcare

Tweets about $NARI

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats